2005
DOI: 10.3892/ijo.27.4.949
|View full text |Cite
|
Sign up to set email alerts
|

Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
33
0
2

Year Published

2006
2006
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 34 publications
(39 citation statements)
references
References 0 publications
4
33
0
2
Order By: Relevance
“…TCF/LEF-1 is a downstream regulator of the Wnt signaling pathway, which has been shown to correlate with ER status in tumors and, interestingly, has been shown to inhibit tumor cell invasion in Matrigel assays when overexpressed (38). Furthermore, Lef-1 knockout mice fail to develop mammary glands (24), confirming a role for LEF-1 in mammary cells and breast cancer.…”
Section: Discussionmentioning
confidence: 85%
“…TCF/LEF-1 is a downstream regulator of the Wnt signaling pathway, which has been shown to correlate with ER status in tumors and, interestingly, has been shown to inhibit tumor cell invasion in Matrigel assays when overexpressed (38). Furthermore, Lef-1 knockout mice fail to develop mammary glands (24), confirming a role for LEF-1 in mammary cells and breast cancer.…”
Section: Discussionmentioning
confidence: 85%
“…TCF/ LEF and nuclear b-catenin expression correlate with invasiveness in colon carcinoma and over-expression induces invasion in model cell lines (Nguyen et al, 2005). Like both Ets-1 and NF-kB, TCF/LEF has been shown to synergistically regulate MMP genes with AP-1 via direct interaction with c-Jun (Rivat et al, 2003).…”
Section: Tcf/lefmentioning
confidence: 99%
“…It has been reported to be essential for EMT processes during gastrulation, somitogenesis, limb development, delamination and fate specification of neural crest cells and palate fusion [Oosterwegel et al, 1993;Takeda et al, 2000;Skromne and Stern, 2001;Nawshad and Hay, 2003;Schmidt et al, 2004], and its activator ␤ -catenin is critical for heart cushion formation [Liebner et al, 2004]. Besides these roles during development, an increasing number of studies reports either upregulation or aberrant activation of LEF-1 during cancer progression in various organs including colon, skin, breast, blood and lymph nodes [Rubinfeld et al, 1997;Brabletz et al, 2001;Li et al, 2004;Waterman, 2004;Nguyen et al, 2005;Simon et al, 2005;Howe and Bromidge, 2006] and suggest LEF-1 to play a role downstream of ␤ -catenin also in lung, kidney, cervical and ovarian carcinomas [Ueda et al, 2001].…”
Section: ␤ -Catenin/lef In Developmentmentioning
confidence: 99%